• HCI was selected in late 2009 by Octapharma to become one of five Specialty Biopharmaceutical Distributors to launch Wilate commencing May 2010
  • Ranked one of four First Tier Distributors in 2008 and 2005 by MRB (Marketing Research Bureau)
  • HCI was selected in 2007 by Nabi Biopharmaceuticals as the sole Specialty Biopharmaceutical Distributor for Nabi HB. HCI continues to maintain that same role with Biotest Pharmaceuticals since their purchase of Nabi Biopharmaceuticals in 2007
  • HCI was the sole Authorized Distributor of Record (ADR) involved in the exclusive launch of Hepagam B in 2006 for Apotex
  • HCI was awarded the Corporate Member Silver Level in recognition of our support for the National Home Infusion Association (NHIA) in 2006 and 2005
  • HCI was selected as one of four nationwide partners for Gammagard S/D in early 2004
  • HCI was recognized by Aventis Behring, LLC as Preferred Partner in Distribution in 2002
  • HCI was awarded recognition of outstanding Achievement by Bayer Pharmaceutical Division in 1999
  • Our CEO and President, Walter R. Shikany, Jr., was awarded a Certificate of Appreciation for his continued commitment in helping others, presented by Armour Pharmaceutical Company in 1995
  • HCI was selected by Univax as one of five Nationwide Partners to bring WinRho to the US Market in 1995
  • HCI was the primary partner and assumed a major role during Baxters Gammagard S/D launch in mid-1994
  • HCI was one of two partners to bring Gammar IV to the US marketplace in December 1990